CIHR Operating Grant: Addressing the Wider Health Impacts of COVID-19
Launched in early September, this funding opportunity seeks research proposals to address the gaps in knowledge about the wider impacts of the COVID-19 pandemic and response on the health and health care of people in Canada. Suspension/interruption of cancer screening is one of the research areas of focus.
The maximum amount per grant that can be requested for clinical trial research is $1,000,000 over 2 years; for other types of research, the maximum amount per grant is $500,000 over 2 years. Registration deadline is October 18, 2021. For more information, see https://www.researchnet-recherchenet.ca/rnr16/vwOpprtntyDtls.do?prog=3548&language=E.
2020 ARCC Conference on May 25 and 26
Registration for the 2020 ARCC Conference, which will take place in Saskatoon on May 25 and 26, is NOW OPEN! Click Here to Register. Plenary themes for 2020 include Real World Evidence, Dat... Read More »
Registration for the 2020 ARCC Conference, which will take place in Saskatoon on May 25 and 26, is NOW OPEN! Click Here to Register. Plenary themes for 2020 include Real World Evidence, Dat... Read More »
Are You the Next Scientific Director of CIHR’s Institute of Cancer Research?
As you know, the CIHR-ICR funds cancer research in Canada based on internationally accepted standards of excellence with the goal of reducing the burden of cancer on individuals and is dedicated to creating and maintaining a robust cancer research environment in Canada. This posit... Read More »
As you know, the CIHR-ICR funds cancer research in Canada based on internationally accepted standards of excellence with the goal of reducing the burden of cancer on individuals and is dedicated to creating and maintaining a robust cancer research environment in Canada. This posit... Read More »